Comparison of Body Composition & Weight Change in Users of Progestin-only Contraception During the First Year of Use
Overview
The purpose of this study is to learn if women gain weight using progestin-only methods of contraception and if so, how much. The investigators will look at users of two progestin-only methods: the levonorgestrel-containing intrauterine contraceptive (LNG-IUC) and the etonorgestrel (ENG) subdermal implant, and compare these users' weight change to that of users of a non-hormonal method, the copper intrauterine device. The primary hypothesis is that ENG implant and LNG-IUC users' weight and body composition will increase more than the copper-IUD users. The investigators will collect body composition data using dual-energy x-ray absorptiometry (DEXA), and collect information about diet and activity using validated questionnaires.
Full Title of Study: “Comparison of Body Composition & Weight Change in Users of Progestin-only Contraception During the First Year of Use”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Prospective
- Study Primary Completion Date: August 2014
Clinical Trial Outcome Measures
Primary Measures
- Weight
- Time Frame: Baseline and 12 months
- Compare changes in body weight and BMI measurements
Secondary Measures
- Body composition
- Time Frame: Baseline and 12 months
- Compare parameters including fat mass and percentage and central-to-peripheral fat ratios
Participating in This Clinical Trial
The study has finished enrolling new participants. Inclusion Criteria:
- Participants between the ages of 18 and 45 years – Participants starting the copper IUD or implant through their provider – First study visit must occur within 14 days of method insertion Exclusion Criteria:
- DMPA in the past 16 weeks – POPs, LNG-IUC, or the implant in the past 4 weeks – Thyroid disease – Autoimmune disease – Diabetes (excluding gestational) – History of eating disorder – Currently taking antidepressants for < 6 months – Currently taking antipsychotics – Currently taking oral glucocorticoids (steroids, i.e. prednisone) for more than 6 months – Currently breastfeeding – Less than 6 months post-partum
Gender Eligibility: Female
Minimum Age: 18 Years
Maximum Age: 45 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Washington University School of Medicine
- Provider of Information About this Clinical Study
- Sponsor
- Overall Official(s)
- Tessa E Madden, MD, MPH, Principal Investigator, Washington University School of Medicine
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.